Toward large-scale mass spectrometry-based omics for clinical applications

Recent technical and methodological advancements in mass spectrometry analysis have propelled healthcare toward a tipping point, shifting from traditional RNA- and DNA-based research to downstream analysis of protein, lipid, and metabolite effectors.

Authors

Maor Arad (ORCID: https://orcid.org/0000-0003-4618-9868)
Leonard J. Foster

Institutions

University of British Columbia (CA)

Publication Details

Journal: Expert Review of Proteomics
Published: 2026-03-04
DOI: https://doi.org/10.1080/14789450.2026.2646657
Primary Topic: Metabolomics and Mass Spectrometry Studies
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Toward large-scale mass spectrometry-based omics for clinical applications

Maor Arad, Leonard J. Foster

Mar 4, 2026

Expert Review of Proteomics

Metabolomics and Mass Spectrometry Studies

article

Toward large-scale mass spectrometry-based omics for clinical applications

Maor Arad, Leonard J. Foster

March 4, 2026article en

Abstract

Expert Review of ProteomicsVol. 23(3)

University of British Columbia (CA)

Openalex Percentile: Top 22%

Metabolomics and Mass Spectrometry Studies

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Toward large-scale mass spectrometry-based omics for clinical applications — Maor Arad, Leonard J. Foster · Expert Review of Proteomics (2026) | TGRS Research Map | TGRS